Lv11
12 积分 2020-07-25 加入
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
2小时前
待确认
The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma
3小时前
已完结
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
1个月前
已完结
Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner
1个月前
已完结
DPP4 inhibition reveals interleukin-33-dependent eosinophil-mediated tumor immunity in hepatocellular carcinoma
1个月前
已完结
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy
1个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
1个月前
已完结
Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy
1个月前
已完结
Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors
1个月前
已完结
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
1个月前
已完结
皖公网安备34019202002308
